Literature DB >> 19013287

Regulation of adiponectin secretion by insulin and amino acids in 3T3-L1 adipocytes.

Regje M E Blümer1, Cindy P van Roomen, Alfred J Meijer, Judith H P M Houben-Weerts, Hans P Sauerwein, Peter F Dubbelhuis.   

Abstract

Adiponectin is a fat cell-derived hormone with insulin-sensitizing properties. Low plasma adiponectin levels are associated with insulin resistance as found in obesity. One of the mechanisms for this finding is hampered insulin signaling via phosphatidylinositol 3-kinase (PI3K) with concomitant decreased adiponectin secretion. Because insulin can also stimulate signaling at the level of mammalian target of rapamycin (mTOR) by a mechanism that is dependent on the presence of amino acids, the role of mTOR signaling in adiponectin secretion was studied. In view of the vesicular nature of adiponectin secretion, the role of lysosomes was explored as well. In 3T3-L1 adipocytes, both insulin and amino acids stimulated adiponectin secretion. The stimulation by insulin was PI3K dependent but mTOR independent. The stimulation by amino acids was independent of both PI3K and mTOR. Whereas the effect of insulin via PI3K was mainly on adiponectin secretion from adipocytes, the effect of amino acids was predominantly due to their role as substrates for adiponectin synthesis. The acidotropic agents ammonia and methylamine, but not the lysosomal protease inhibitor leupeptin and the autophagy inhibitor 3-methyladenine, strongly inhibited adiponectin secretion and increased the intracellular adiponectin pool. In conclusion, adiponectin production is substrate driven. Phosphatidylinositol 3-kinase and an acidic lysosomal pH, but not amino acid-mediated mTOR signaling or lysosomal breakdown, are involved in adiponectin secretion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013287     DOI: 10.1016/j.metabol.2008.07.020

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  25 in total

Review 1.  Branched-chain amino acids differently modulate catabolic and anabolic states in mammals: a pharmacological point of view.

Authors:  Francesco Bifari; Enzo Nisoli
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

2.  Insulin and adipokine signaling and their cross-regulation in postmortem human brain.

Authors:  Hoau-Yan Wang; Ana W Capuano; Amber Khan; Zhe Pei; Kuo-Chieh Lee; David A Bennett; Rexford S Ahima; Steven E Arnold; Zoe Arvanitakis
Journal:  Neurobiol Aging       Date:  2019-08-20       Impact factor: 4.673

3.  Relationship of adiponectin and leptin with autoimmunity in children with new-onset type 1 diabetes: a pilot study.

Authors:  Natalie Hecht Baldauff; Hala Tfayli; Wenxiu Dong; Vincent C Arena; Nursen Gurtunca; Massimo Pietropaolo; Dorothy J Becker; Ingrid M Libman
Journal:  Pediatr Diabetes       Date:  2015-03-05       Impact factor: 4.866

4.  Template to improve glycemic control without reducing adiposity or dietary fat.

Authors:  R Krishnapuram; E J Dhurandhar; O Dubuisson; H Kirk-Ballard; S Bajpeyi; N Butte; M S Sothern; E Larsen-Meyer; S Chalew; B Bennett; A K Gupta; F L Greenway; W Johnson; M Brashear; G Reinhart; T Rankinen; C Bouchard; W T Cefalu; J Ye; R Javier; A Zuberi; N V Dhurandhar
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-01-25       Impact factor: 4.310

5.  Metabolomics allows the discrimination of the pathophysiological relevance of hyperinsulinism in obese prepubertal children.

Authors:  G Á Martos-Moreno; A Mastrangelo; V Barrios; A García; J A Chowen; F J Rupérez; C Barbas; J Argente
Journal:  Int J Obes (Lond)       Date:  2017-06-07       Impact factor: 5.095

6.  The multimerization and secretion of adiponectin are regulated by TNF-alpha.

Authors:  Yiduo He; Linfang Lu; Xuan Wei; Dan Jin; Tao Qian; An Yu; Jun Sun; Jiesheng Cui; Zaiqing Yang
Journal:  Endocrine       Date:  2015-09-25       Impact factor: 3.633

Review 7.  Recent Advances in Adipose mTOR Signaling and Function: Therapeutic Prospects.

Authors:  Huan Cai; Lily Q Dong; Feng Liu
Journal:  Trends Pharmacol Sci       Date:  2015-12-14       Impact factor: 14.819

8.  PKA-independent cAMP stimulation of white adipocyte exocytosis and adipokine secretion: modulations by Ca2+ and ATP.

Authors:  Ali M Komai; Cecilia Brännmark; Saliha Musovic; Charlotta S Olofsson
Journal:  J Physiol       Date:  2014-09-05       Impact factor: 5.182

9.  Lipoic acid inhibits adiponectin production in 3T3-L1 adipocytes.

Authors:  Pedro L Prieto-Hontoria; Marta Fernández-Galilea; Patricia Pérez-Matute; J Alfredo Martínez; María J Moreno-Aliaga
Journal:  J Physiol Biochem       Date:  2013-01-12       Impact factor: 4.158

10.  Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1.

Authors:  Jennifer C Carter; Frank C Church
Journal:  PPAR Res       Date:  2009-08-06       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.